Steven Cohen's WHWK Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 57,129 shares of Whitehawk Therapeutics, Inc. (WHWK) worth $261,651, representing 0.00% of the portfolio. First purchased in 2022-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Steven Cohen has maintained this position in WHWK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2022, adding 330,513 shares. Largest reduction occurred in Q4 2022, reducing 501,063 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Whitehawk Therapeutics (WHWK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Whitehawk Therapeutics (WHWK) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +29,103 | Add 103.84% | 57,129 | $4.58 |
| Q1 2026 | +28,026 | New Buy | 28,026 | $3.45 |
| Q2 2023 | -86 | Sold Out | 0 | $0.00 |
| Q1 2023 | -65,980 | Reduce 99.87% | 86 | $7.24 |
| Q4 2022 | -501,063 | Reduce 88.35% | 66,066 | $12.83 |
| Q3 2022 | +25,085 | Add 4.63% | 567,129 | $14.13 |
| Q2 2022 | +330,513 | Add 156.25% | 542,044 | $12.32 |
| Q1 2022 | +211,531 | New Buy | 211,531 | $16.97 |
Steven Cohen's Whitehawk Therapeutics Investment FAQs
Steven Cohen first purchased Whitehawk Therapeutics, Inc. (WHWK) in Q1 2022, acquiring 211,531 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Whitehawk Therapeutics, Inc. (WHWK) for 8 quarters since Q1 2022.
Steven Cohen's largest addition to Whitehawk Therapeutics, Inc. (WHWK) was in Q2 2022, adding 542,044 shares worth $6.68 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 57,129 shares of Whitehawk Therapeutics, Inc. (WHWK), valued at approximately $261,651.
As of the Q2 2026 filing, Whitehawk Therapeutics, Inc. (WHWK) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Whitehawk Therapeutics, Inc. (WHWK) was 567,129 shares, as reported at the end of Q3 2022.